青霉素过敏与组织扩张器乳房重建术后并发症风险的倾向评分匹配回顾性队列研究
本研究基于TriNetX数据库,纳入组织扩张器乳房重建患者,按青霉素过敏史分组并进行倾向评分匹配,每组1868例。结果显示,青霉素过敏组术后90天植入物感染、手术部位感染、抗生素使用、急诊就诊及扩张器取出的风险均显著高于对照组,提示青霉素过敏史与该人群术后感染并发症风险升高相关。
要点
- 青霉素过敏史者组织扩张器乳房重建术后90天植入物感染风险升高(RR 1.41,p=0.003)。
- 该人群手术部位感染(RR 1.54,p=0.042)及扩张器取出(RR 1.20,p=0.044)风险亦显著增加。
- 抗生素使用(RR 1.38,p<0.001)与急诊就诊(RR 1.75,p<0.001)风险同样升高。
核心结论
- 在组织扩张器乳房重建患者中,报告青霉素过敏史与植入物感染及相关术后并发症风险显著升高相关。
研究设计与样本
- 倾向评分匹配的回顾性队列研究,数据来源于TriNetX数据库,匹配后每组1868例。
主要发现
- 术后90天,青霉素过敏组植入物感染风险比(RR)为1.41(p=0.003)。
- 术后90天,手术部位感染RR为1.54(p=0.042),抗生素使用RR为1.38(p<0.001)。
- 术后90天,急诊就诊RR为1.75(p<0.001),扩张器取出RR为1.20(p=0.044)。
- 术后30天和60天也部分观察到风险升高。
临床怎么用
- 对拟行组织扩张器乳房重建且报告青霉素过敏的患者,应重视术后感染相关并发症的监测与预防。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Reported penicillin allergy often leads to avoidance of first-line β-lactam prophylaxis in favor of less effective alternatives, potentially increasing surgical site infection (SSI) risk. Tissue expander (TE)-based breast reconstruction, despite being a clean procedure, has infection rates of up to 30%. This study evaluates whether reported penicillin allergy is associated with increased postoperative infection risk in this population. METHODS: The TriNetX database was queried to identify patients who underwent TE-based breast reconstruction. Patients were stratified into two cohorts: those with a documented history of penicillin allergy and those without. Propensity score matching was applied to balance infection-related risk factors. The primary outcome was implant infection, while secondary outcomes were SSI, wound dehiscence, emergency department visits, antibiotic uses, and TE removals. Outcomes were assessed at 30, 60, and 90 days postoperatively. RESULTS: After matching, 1868 patients were included in each cohort. At 90 days following surgery, patients with a history of penicillin allergy had significantly increased risks of implant infection (risk ratio [RR] 1.41, p=0.003), SSI (RR 1.54, p=0.042), antibiotic uses (RR 1.38, p<0.001), emergency department visits (RR1.75, p<0.001), and TE removals (RR 1.20, p=0.044), compared to matched controls. Elevated risks were also partly observed at 30 and 60 days postoperatively. CONCLUSION: In this large retrospective study of TE-based breast reconstruction, a reported history of penicillin allergy was associated with significantly higher risks of implant infection and related postoperative complications compared with patients without such a history.
引用
- Lee S, Posso AN, Neira M, et al. Postoperative complication risks associated with penicillin allergy in tissue expander-based breast reconstruction: A propensity score-matched retrospective cohort study. J Plast Reconstr Aesthet Surg. 2026. PMID: 42879875. doi:10.1016/j.bjps.2026.10.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。